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THE RELATIONSHIP BETWEEN ENDOGENOUS CREATINE LEVELS AND 
MAXIMAL UPPER BODY STRENGTH, SHORT TERM MUSCLE RECOVERY AND 
BODY FAT IN MALES 
by 
Vincent James Dalbo III 
(Under the Direction of Jim McMillan) 
ABSTRACT 
Numerous studies have found creatine supplementation to positively enhance 
performance but no research found has examined the effects of endogenous creatine 
levels on performance. The purpose of this study was twofold. First we examined 
correlations between endogenous creatine levels and strength, absolute strength, short 
term muscle recovery and body fat. We also examined the effects of creatine 
supplementation with a sufficient washout period on plasma creatinine levels. 
Participants consisted of 24 healthy men who met with the experimenter twice over a 4 
day period. Significant positive correlations (p ≤ .05) were found between creatine and 
strength, absolute strength, lean body mass and muscle recovery as a function of total 
weight lifted following 3 and 5 sets of the muscle fatigue protocol.    
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CHAPTER 1 
INTRODUCTION 
Creatine is stored in the liver, brain, kidneys and testes (Persky & Brazeau, 2001) 
but 95% (Balsom, Soderlund, & Ekblom, 2004; Grande & Graves, 2005) to 98% of 
creatine is stored in skeletal muscle (Peeters, Lantz, & Mayhew, 1999) as creatine is 
directly involved in muscular contractions (Grande & Graves, 2005). During creatine 
supplementation total creatine content in muscle has been found to increase by 10%-20% 
with 20%-40% of increased intramuscular creatine being stored as phosphocreatine 
(Kreider, Ferreira, Wilson, Grindstaff, Plisk, Reinardy, et al., 1998). The increased 
creatine content in muscles enhances the phosphagen system (Almada, Kreider, Ferreira, 
Wilson, Grindstaff, Plisk, et al., 1997; Bosco, Tihanyi, Pucspk, Kovacs, Gobossy, Colli, 
et al., 1997; Casey, Constantin-Teodosiu, Howell, Hultman, & Greenhaff, 1996; Earnest, 
Snell, Rodriguez, Almada, & Mitchell, 1995; Ferreira, Kreider, Wilson, Grindstaff, Plisk, 
Reinhardy, et al., 1997; Grindstaff, Kreider, Bishop, Wilson, Wood, Alexander, et al., 
1997; Harris, Viru, Greenhaff, & Hultman, 1993; Kirksey, Warren, Stone, Stone, & 
Johnson, 1997; Kreider et al., 1998; Kreider, 1998; Prevost, Nelson, & Morris, 1997; 
Rawson & Volek, 2003; Skare, Skadberg, & Wisnes, 2001) allowing users to maintain 
higher levels of performance for longer durations of time.  
Over 200 studies have been conducted examining the effects of creatine 
supplementation on athletic performance since 1993 (Rawson & Volek, 2003) and in 
2000 The American College of Sports Medicine (ACSM) released a position statement 
claiming creatine supplementation can improve high intensity, short duration 
performance especially during repeated exercise bouts (ACMS, 2000; Rawson & Volek; 
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Terjung, Clarkson, Eichner, Greenhaff, Hespel, Israel, et al., 2000). However, not all 
creatine supplementation studies have resulted in significant performance improvements 
as it may be necessary to increase total muscle creatine by close to 20 mmol·kg-1 dry 
weight (dw) from creatine supplementation to obtain significant performance 
improvements (Greenhaff, Bodin, Soderlund, & Hultman, 1994). Research has identified 
three interindividual responses to creatine supplementation: responders, individuals who 
experience a > 20 mmol·kg-1 dw increase in total intramuscular creatine monohydrate 
plus phosphorylated creatine (Greenhaff, Bodin, Soderlund, & Hultman; Syrotuik & Bell, 
2004); quasi responders, individuals who experience between a 10-20 mmol·kg-1 dw 
increase and nonresponders, individuals who experience < 10 mmol·kg-1 dw increase 
(Syrotuik & Bell). It has been established that performance increases are correlated to the 
amount of creatine that is absorbed during creatine supplementation (Syrotuik & Bell) 
and this correlation is prominently displayed in vegetarians who have lower endogenous 
creatine levels than non-vegetarians and have been found to tend to experience greater 
benefits from creatine supplementation (Rae, Digney, McEwan, & Bates, 2003; Shrier, 
2004).  
Numerous studies have found creatine supplementation to increase muscular 
strength (Greenhaff, Casey, Short, Harris, Soderlund, & Hultman, 1993; Balsom, 
Soderlund, Sjodin, & Ekblom, 1995; Earnest, Snell, Rodriguez, Almada, & Mitchell, 
1995; Rawson, Clarkson, Price, & Miles, 2002; Vandenberghe, Goris, Van Hecke, Van 
Leemputte, Vangerven, & Hespel, 1997; Vandenberghe, Van Hecke, Van Leemputte, 
Vanstapel, & Hespel, 1999), short term muscle recovery (Almada et al., 1997; Bemben & 
Lamont, 2005; Bosco et al., 1997; Kreider, 1998) and fat-free mass (Becque, Lochmann, 
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& Melrose, 1997; Becque, Lochmann, & Melrose, 2000; Earnest, Snell, Rodriguez, 
Almada, & Mitchell, 1995; Haff, Kirsey, & Stone, 1999; Kreider et al., 1998; Kreider, 
Grindstaff, Wood, Bullen, Klesges, & Lotz, 1996; Maganaris and Maughan, 1998; 
Rawson, Clarkson, Price, & Miles, 2002; Vandenberge et al., 1997) but no research 
found has examined the effects of endogenous creatine levels on performance or body 
composition even though endogenous creatine levels normally range between 120-140 g 
dry mass (dm) (Rawson & Volek, 2003; Sarubin-Fragakis), with studies finding 
endogenous creatine levels ranging from 100-150 mmol/kg dm (Harris, Hultman, & 
Norjedo, 1974; Steenge, Simpson, & Greenhaff, 2000). 
The normal variability in endogenous creatine levels (20 g dm) is equivalent to 
the proposed amount of creatine that must be absorbed during creatine supplementation 
to obtain significant performance improvements. Therefore we expect endogenous 
creatine levels to be positively correlated with strength, absolute strength determined by 
subtracting body weight from one repetition maximum strength and short term muscle 
recovery while being negatively correlated with body fat percentage. Additional analyses 
were conducted to examine if past creatine supplementation followed by an appropriate 
washout period of 4 months (Rawson, Persky, Price, & Clarkson, 2004) had an effect 
creatinine levels; as it is unknown if new steady-state relations occur between creatine 
and creatinine during periods of prolonged creatine supplementation (Culpepper, 1998).  
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CHAPTER 2 
METHODS 
Participants 
Each participant was required to be a student at Georgia Southern University and 
had to have at least 1 year of resistance training experience (M = 4.80, SD = 3.03 years) 
to reduce the effect of strength differences due to technique. Participants were also 
required to bench press their body weight and could not have consumed an ergogenic aid 
over the past 2 months or a creatine supplement in the previous 4 months. Data were 
collected on 40 male participants but only 23 participants were included in the study. 
Participants were eliminated because of suspected creatine supplementation (1), blood 
lysing (2) during the blood draw which negatively affected the accuracy of the creatinine 
reading. Resistance training during the course of the study (1), failure to meet the strength 
requirement (2), consuming a creatine supplement (2), consuming an ergogenic aid (4) 
and (5) failing to return the food log. Each participant was informed of the procedures 
involved in the study along with the risks and benefits of participation. Informed consent 
was obtained after approval from the Institutional Review Board. 
Procedures 
Participants met with the experimenter twice during a four day period. During the 
first meeting participants read and signed the informed consent (see Appendix C) and 
were instructed how to record a three day food diary (see Appendix D). Nutritional data 
were recorded to ensure no significant changes in energy or macronutrient consumption 
occurred between participants over the duration of the study. Data were analyzed using 
Diet Analysis Plus (7.0, DA PLUS). Next, participants completed a demographic 
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questionnaire that contained questions assessing the use of ergogenic aids, current 
physical activity level and weight training experience (see Appendix E). Then the 
experimenter demonstrated and described proper bench press technique to each 
participant using the standards described by the National Strength and Conditioning 
Association (NSCA) (Baechle & Earle, 2000, see Appendix F). Participants then 
practiced bench press technique for 2 sets of 5 repetitions with approximately 50% of 
their bodyweight. Participants were then reminded to refrain from resistance training for 
the duration of the study and to fast for 8 hours prior to the next meeting with the 
experimenter.  
Three days later, during the second meeting, participants returned their 3 day food 
log. Next height, weight and body fat percentage (using the 3-site Jackson Pollack 
skinfold equation) (Jackson & Pollack, 1985, see Appendix G) of each participant were 
recorded followed by a 10 mL blood draw from the left antecubital vein by a registered 
nurse. Blood was collected in a Vacutainer Glass Whole Blood Tube with heparin (Mfr. 
No.: 366535, Fisher Scientific, St. Louis, MO), centrifuged and pipetted to separate the 
plasma from the blood and the plasma was frozen for later analysis. Participants were 
then tested for strength using procedures set forth by the NSCA (Baechle & Earle, 2000, 
see Appendix H). Five minutes following completion of the one repetition maximum test 
participants performed five bench press sets to failure with 80% of their one repetition 
maximum with two minute rest periods between sets to determine the correlation between 
endogenous creatine levels and short term muscle recovery. Participants were verbally 
encouraged to give maximal effort during each lift.  
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Creatine Determination 
The body surface area of each participant was calculated (see Figure 1), divided 
by 1.73 m2 and multiplied by 120 g giving an estimate of endogenous creatine levels. 
(Delanghe, De Slypere, De Buyzere, Robbrecht, Wieme, & Vermeulen, 1989).   
 
Figure 1. Calculation of body surface area (BSA) 
________________________________________________________________________ 
BSA = ((body weight x height) / 3125)1/2 
Body weight in pounds 
Height in inches 
BSA is calculated in square meters 
________________________________________________________________________ 
 
Creatinine Determination   
Blood samples were centrifuged (MARATHON 21 K/R, Fisher Scientific, St. 
Louis, MO) at 850 x g for 10 minutes at 4 degrees Celsius. Then plasma was pipetted 
from the Vacutainer into 2 separate vials and immediately frozen at -80 degrees Celsius 
for later analysis using a creatinine kit (500701 from Cayman Chemical Company, Ann 
Arbor, MI). For creatinine determination plasma samples were thawed at room 
temperature (~74 degrees Celsius) and 8 standards were prepared by mixing the 
creatinine standard with HPLC-grade water. Next plasma samples were placed on a 
Votex mixer and 15 µl of the creatinine sample were pipeted into three wells using a 
multichannel adjustable volume micropipette (Finnpipett, Thermo electron Corporation, 
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Waltham, MA). A new pipette tip was used for each sample during each step of the 
procedure. Then the reaction was started by adding 150 µl of an alkaline picrate solution 
and the plate containing the samples was covered with a plate cover and mixed on an 
orbital shaker (Maxi Mix II, Type 37600 Mixer, Barnstead/Thermolynce, Dubuque, IA) 
for 10 minutes at a low speed. The plate cover was removed and the samples were gently 
blown on to pop excess bubbles. Initial absorbance values were read at 492 nm on a plate 
reader (Spectromax 340, SOFTmaxPro 2.6.1, Sunnyvale, CA). The plate was removed 
from the plate reader and 5 µl of acid solution was added to each well. The plate was 
covered with the plate cover and mixed on an orbital shaker for 20 minutes at a low 
speed. The plate cover was removed and the samples were gently blown on to pop excess 
bubbles. Final absorbance values were read at 492 nm on a plate reader. For the extended 
creatinine analysis see Appendix I. 
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CHAPTER 3 
RESULTS 
 Plasma creatinine levels were determined in triplicate (M = 1.152, SD = .267 
mg/dl) with an intraclass correlation coefficient of r = .947. Endogenous creatine levels 
were found to be significantly (p ≤ .05) positively correlated with strength (r = .797,        
p < 0.001) and absolute strength (r = .456, p = 0.029). Endogenous creatine levels were 
not found to be correlated with short term muscle recovery when examining total 
repetitions after three (r = -.144, p = 0.512) or five sets (r = -.124, p = 0.574); however, 
when examining the correlation between endogenous creatine levels and total weight 
lifted (weight lifted x repetitions) as a measure of short term muscle recovery significant 
positive correlations were found after three sets (r = .503, p = 0.014) and five sets           
(r = .522, p = 0.011). Endogenous creatine levels were not found to be correlated with 
body fat percentage (r = .292, p = 0.177) but were significantly positively correlated with 
lean body mass (r = .524, p = 0.010). Additional significant correlations were found 
between creatine and height (r = .876, p < 0.001), weight (r = .989, p < 0.001), years of 
resistance training (r = .701, p < 0.001) and current amount of repetitions performed 
while resistance training (r = -.683, p = 0.003). 
 Results from independent t-tests revealed participants who previously used a 
creatine supplement to have significantly (p = 0.005) higher endogenous creatine levels 
than participants who never used a creatine supplement. Additionally those who had used 
a creatine supplement had significantly more resistance training experience (p = 0.002) 
weighed more (p = 0.004) and had a higher body fat percentage (p = 0.001) than 
participants who have never used a creatine supplement. Moreover no difference in 
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creatinine levels were found between participants who had and had not consumed a 
creatine supplement (p = .941). For descriptive statistics see Table 1. 
 
Table 1  
Participant Descriptive Statistics    
Descriptive Statistics  M SD 
Age 20.91 3.04 years 
Height 68.61 2.59 inches 
Body Weight (BW) 172.57 20.30 pounds 
Body Fat Percentage 13.14 5.75 % 
Lean Body Mass 152.57 12.15 pounds 
1 Repetition Maximum (RM) 222.61 40.73 pounds 
Absolute Strength (1RM – BW) 50.04 27.13 pounds 
Repetitions Set 1 (80% 1 RM) 6.43 1.80 reps 
Repetitions Set 2 (80% 1 RM) 4.35 1.07 reps 
Repetitions Set 3 (80% 1 RM) 3.13 1.01 reps 
Repetitions Set 4 (80% 1 RM) 2.43 0.66 reps 
Repetitions Set 5 (80% 1 RM) 2.22 0.60 reps 
Total Repetitions (Three Sets) 13.91 3.07 reps 
Total Repetitions (Five Sets) 18.57 3.92 reps 
Calorie Consumption 2737.82 913.08 calories 
Protein Consumption 114.75 43.22 grams 
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CHAPTER 4 
DISCUSSION 
 The majority of research has found creatine supplementation to increase strength, 
muscle recovery and fat free mass with the most recent research finding a positive 
relationship between the amount of creatine absorbed from creatine supplementation and 
performance improvements (Greenhaff, Bodin, Soderlund, & Hultman, 1994, Syrotuik & 
Bell, 2004). Interindividual differences in endogenous creatine levels have been found to 
vary as much as 50 g so it is reasonable to believe endogenous creatine levels could effect 
strength, short term muscle recovery and fat free mass as much as creatine 
supplementation. 
Endogenous Creatine and Strength 
Bench press was used to assess strength because the majority of creatine 
supplementation studies have measured strength using bench press or leg press 
performance. Endogenous creatine levels were found to be significantly correlated with 
strength and absolute strength. The correlation between endogenous creatine levels and 
absolute strength is particularly important because strength has been found to be related 
to body weight and body weight has been found to be correlated with creatine (Mosteller, 
1987). Absolute strength negated the effects of body weight on strength by subtracting 
each participants body weight from the amount of weight lifted. Arciero, Hannibal, 
Nindl, Gentile, Hamed and Vukovich (2001) found 40% of increases in strength during 
creatine supplementation occur independent of exercise and the results from this study 
suggest that 63.5% of variance in upper body strength can be accounted for by 
endogenous creatine levels.  
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Endogenous Creatine and Short Term Muscle Recovery     
 The primary effect of creatine supplementation is to enhance the phosphagen 
system (Almada et al., 1997; Bosco et al., 1997; Casey, Constantin-Teodosiu, Howell, 
Hultman, & Greenhaff, 1996; Earnest, Snell, Rodriguez, Almada, & Mitchell, 1995; 
Ferreira et al., 1997; Grindstaff et al., 1997; Harris, Viru, Greenhaff, & Hultman, 1993; 
Kirksey, Warren, Stone, Stone, & Johnson, 1997; Kreider et al., 1998; Kreider, 1998; 
Prevost, Nelson, & Morris, 1997; Rawson & Volek; Skare, Skadberg, & Wisnes, 2001) 
by increasing total creatine content in muscles (Kreider et al., 1998) allowing users to 
train harder for longer durations of time (Rawson & Volek, 2003). This study mimicked a 
muscle fatigue protocol used by Kelly and Jenkins (1998). When using total repetitions 
performed after three sets and five sets no significant correlations were found between 
endogenous creatine and short term muscle recovery, most likely a function of 
participants with higher creatine levels lifting significantly heaver weights. When 
examining short term muscle recovery as a function of the total amount of weight lifted a 
statistically significant correlation was found between creatine and short term muscle 
recovery because participants with higher endogenous creatine levels were lifting greater 
amounts of weight for the same amount of repetitions. 
Endogenous Creatine and Fat Free Mass          
The majority of research has found creatine supplementation to positively 
influence body mass as studies have found creatine supplementation to increase fat free 
mass (Becque, Lochmann, & Melrose, 1997; Becque, Lochmann, & Melrose, 2000; 
Earnest, Snell, Rodriguez, Almada, & Mitchell, 1995; Haff, Kirsey, & Stone, 1999; 
Kreider et al., 1998; Kreider, Grindstaff, Wood, Bullen, Klesges, & Lotz, 1996; 
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Maganaris & Maughan, 1998; Rawson, Clarkson, Price, & Miles, 2002; Vandenberge et 
al., 1997) and lean body mass (Flisinska-Bojanowska, 1996; Haff, Kirksey, & Stone; 
Kirksey, Stone, Warren, Johnson, Stone, et al., 1999; Maganaris & Maughan, 1998; 
Rawson, Clarkson, Price, & Miles; Noonan, Berg, Latin, Wagner, & Reimers, 1998; 
Vandenberge et al., 1997) but a few studies have not found creatine supplementation to 
have a statistically significant effect on body fat percentage (Kirksey et al. 1997; Noonan, 
Berg, Latin, Wagner, & Reimers). Results from this study were equivocal in regard to the 
effects of endogenous creatine levels on body mass as no statistically significant 
correlation was found between endogenous creatine levels and body fat percentage, but 
endogenous creatine levels were found to be significantly positively correlated with lean 
body mass.  
Creatine and Creatinine 
A concern surrounding long term creatine supplementation is that a new steady 
state relation between creatine and creatinine may develop (Culpepper, 1998), however 
results from this study were consistent with prior research (Culpepper; Hultman, 
Soderlund, Timmons, Cederblad, & Greenhaff, 1996; Poortmans, Auquier, Renaut, 
Durussel, Saugy, & Brisson, 1997) which have suggested plasma creatinine levels to be 
unaffected by short term creatine supplementation. Future research should focus on the 
effects of long term creatine supplementation on creatinine levels as the possibility of 
new steady state relations forming between creatine and creatinine following long term 
creatine supplementation appears to be the last known disproved danger of long term 
creatine supplementation. Researchers could also examine the effects of endogenous 
creatine levels on aerobic performance as creatine supplementation has been found to 
 22 
enhance some forms of aerobic exercise (Birch, Nobel, & Greenhaff, 1994; Peyrebrune, 
Nevill, & Donaldson, 1998) or the effects of caffeine on endogenous creatine levels as 
caffeine appears to negate the positive effects of creatine supplementation 
(Vandenberghe, Gillis, Van Leemputte, Van Hecke, Vanstaple, & Hespel, 1996). A 
replication of the current study is also noteworthy as the sample size was small and with a 
larger number of participants stronger correlations can be expected.    
Additional Analysis 
Strong significant positive correlations were found between creatine and height 
and weight which is consistent with the work of Mosteller (1987) who found endogenous 
creatine levels to be significantly correlated with body surface area. Endogenous creatine 
levels were also found to be positively correlated with years of resistance training which 
is expected as creatine has been found to be correlated with muscle mass (Culpepper, 
1998). Endogenous creatine was also found to be negatively correlated with the amount 
of repetitions performed while resistance training. 
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Research Hypotheses 
Endogenous creatine levels will be significantly positively correlated with upper body 
strength (α ≤ .05), absolute strength (α ≤ .05) and muscle recovery (α ≤ .05) while being 
negatively correlated to body fat percentage (α ≤ .05). Participants with the highest 
endogenous creatine levels will have the highest one repetition maximum bench press 
lifts relative to body mass, will recover quicker between sets and have low body fat 
percentages than participants with lower endogenous creatine levels. 
 
Limitations 
The study was limited by the following: 
- Not a random sample. 
 
Delimitations 
The study was delimited to the following: 
- All participants were male students from Georgia Southern University. 
- The only exercise used to assess strength and muscle recovery was the bench 
press. 
- All participants had at least one year weight training experience. 
 
Assumptions of the Study 
The conduct of this study was based upon the following assumptions: 
- Sample was representative of the population. 
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- Observations were drawn from normally distributed populations in regards to 
endogenous creatine levels. 
- Observations represented random samples from other populations. 
- Participants had at least one year resistance training experience. 
- Participants gave maximal effort during study. 
- Measures of each participant’s creatine levels were accurate. 
- Participants did not consume an ergogenic aid within two months of the study. 
- Participants did not consume a creatine supplement within four months of the 
study. 
- Received an accurate measure of each participant’s one repetition maximum 
on bench press. 
- The experimenter was able to consistently identify improper technique. 
- Participants properly prepared themselves for testing, getting appropriate 
amounts of sleep and eating properly before the test. 
- Participants accurately recorded their dietary intake. 
 
Definition of Terms 
- Absolute Strength- Maximal one repetition maximum strength minus body 
weight. 
- Failure- The inability to perform a repetition with proper bench press 
technique as defined by the NSCA. 
-    Short term muscle recovery- Will be calculated as the total number of                       
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      repetitions performed after five sets of a muscle fatigue protocol similar to 
       that used by Kelly and Jenkins (1998).  
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Review of Literature 
Effects of Hormones on Endogenous Creatine Levels 
In humans endogenous creatine (Cr) levels achieve homeostasis at approximately 
125 g (range 120 g -140 g) (Sarubin-Fragakis, 2000) which is significantly less Cr than 
the body is capable of storing as Cr levels have been found to reach 195.1 mmol/kg dry 
mass following 5 days of Cr/carbohydrate supplementation at a dose of 20 g per day 
(Green, Hultman, Macdonald, Sewell, & Greenhaff, 1996). Endogenous Cr levels may be 
maintained at significantly lower levels than maximal storage because of the importance 
of arginine, glycine and methionine in the production of proteins and other cell 
constituents such as keratin, ATP, DNA, RNA, GTP, methionine, histones, carnosine and 
norepinephrine (Walker, 1979). Additionally the body appears to have developed 
separate organs for the biosynthesis and utilization of Cr, as tissues responsible for Cr 
biosynthesis do not significantly phosphorylate Cr and the organs responsible for Cr 
biosynthesis do not contain significant amounts of creatine kinase (CK) which is used to 
break down Cr into a usable form of energy. Furthermore mitochondria have been found 
to contain either CK or amidinotransferase which is used in Cr production (Walker). The 
separation of Cr production and utilization has several advantages. First the liver contains 
the enzymes necessary to process dietary components that can be used in endogenous Cr 
production before releasing the nutrients into the blood. Moreover the liver can produce 
Cr from compounds released from muscle and nervous tissues and can slow its 
metabolism through hormonal signals which is beneficial during periods of nutritional 
constraints (Walker).  
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Cr production is most efficient with optimal blood concentrations of insulin, 
somatotropin, thyroid hormone and testosterone (Walker, 1979). Insulin and 
glucocorticoids specifically effect Cr retention and excretion as insulin has been shown to 
enhance Cr uptake in muscle while glucocorticoids have been found to increase plasma 
Cr. Glucocorticoids are particularly important during dietary deficiencies and muscle 
wasting diseases which increase the breakdown of muscle proteins resulting in increased 
levels of amino acids in the liver. Increased levels or arginine and glycine in conjunction 
with decreased protein synthesis promote Cr biosynthesis (Walker).  
Creatine and Phosphocreatine       
During high-intensity, short-duration bouts of exercise lasting approximately 1-14 
seconds the phosphagen system is the primary energy supplier allowing the body to 
function. Cr plays an essential role in the formation of ATP in the phosphagen system 
(Powers & Howley, 2004) and ATP facilitates the phosphorylation of Cr (Walker, 1979). 
As stored ATP begins to be synthesized for movement, phosphocreatine (PCr) initiates 
the process of producing ATP in an attempt to keep ATP levels high. PCr is catalyzed by 
CK to yield Cr, Pi (inorganic phosphate) and energy (ATP) (Powers & Howley). The 
energy from this endergonic reaction is used in an exergonic reaction to combine ADP 
with Pi to yield ATP (Haff, Kirksey, & Stone, 1999; Powers & Howley; Volek & 
Kraemer, 1996). For movement ATP must be broken down by CK (ATPase) to produce 
ADP, Pi and energy (Powers & Howley). Since the phosphagen system relies on PC for 
the production of ATP, as PC levels decline performance decreases because of a 
decreased amount of ATP being supplied to working muscles (Powers & Howley).  
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During strenuous exercise the phosphocreatine energy shuttle acts in contracting 
muscles to regenerate ATP through the return of high-energy phosphate bonds from the 
PCr reserve to produce ATP (Culpepper, 1998). To keep the energy pathway (CK 
reaction) running in a cyclic manner Cr is resynthesized into PCr by other energy 
pathways, currently believed to be oxidative metabolism in the mitochondria (Haff, 
Kirksey, & Stone, 1999). When the oxidative production of ATP exceeds energy needs 
the high-energy phosphate bond of ATP is transferred to Cr to produce PCr in the 
mitochondrial membrane.  
 The phosphocreatine energy shuttle can be described in three stages: the 
peripheral terminus, the intervening space and the energy-generating terminus. The 
phosphocreatine energy shuttle begins at the peripheral terminus which is the site of 
energy utilization and is where isoenzymes of CK rephosphorylate ADP produced via the 
CK reaction allowing muscular contractions. Cr that is produced from the CK reaction 
travels across sites of energy production and utilization known as the intervening space. 
Then Cr transverses in the intervening space and arrives in the energy-generating 
terminus where Cr interacts with isoenzymes of CK to yield PCr from mitochondrial 
ATP. Next regenerated PCr is shuttled back to sites of energy utilization and the process 
of energy production continues.  
ATP is the primary energy source for the body but PCr has a phosphate group 
transfer potential approximately 3 kcal/mol higher than ATP (Walker, 1979) and 
PCr/ATP ratios have been found to vary from 3:1 to 4:1 while PCr/Cr ratios have been 
reported to range from 2:1 to 2.5:1 (Culpepper; 1998; Greenhaff, 1995; Hultman, 
Soderlund, Timmons, Cederblad, & Greenhaff, 1996). Greater quantities of PCr and Cr 
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are stored in favor of ATP because Cr and PCr have a lighter mass and are less negatively 
charged than ATP and ADP which enables greater amounts to be stored in cells without 
disrupting ionic and osmotic balances (Grande & Graves, 2005). Cr and PCr also act as 
energy messengers making each less vulnerable to enzymatic diversion then ATP 
(Walker). ATP and ADP are substrates to hundreds of enzymes while Cr and PCr are 
substrates to only CK which emphasizes the importance of PCr and Cr for providing the 
body with a constant energy source for smooth skeletal muscle contractions which allows 
the heart to pump (Walker) and serves as an energy source for the brain (Rae, Dingney, 
McEway, & Bates, 2003; Wallimann, Wyss, Brdiczka, Nicolay, & Eppenberger, 1992; 
Norwood, Ingwall, Norwood, & Fossel, 1983).  
Cr was first used commercially to promote growth and increase the energy of 
chickens (Walker, 1979) and until the 1960s Cr had to be extracted from raw meat 
(Grande & Graves, 2005). The synthetic production of Cr made the substance widely 
available to the general population and in a matter of a few decades Cr became the most 
popular athletic supplement (Grande & Graves) with sales nearing 100 million dollars in 
1998 (Haff, Kirksey, & Stone, 1999) and exceeding 400 million dollars in 2004 (Grande 
& Graves). 
Positive Benefits of Cr Supplementation 
 In addition to being used as an ergogenic aid Cr supplementation has been found 
to have positive effects on general health and has been used in the treatment of muscle 
wasting diseases (Tarnopolsky, Roy, & MacDonald, 1997). Cr has been used in the 
treatment of gyrate atrophy of the choroid retina (Sipila, Rapola, Simell, & Vannas, 
1981) and has been found to enhance muscle functional capacity along with aerobic and 
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anaerobic performance in people with various forms of neuromuscular diseases 
(Tarnopolsky & Martin, 1999; Walter, Lochmuller, Reilich, Klopstock, Huber, Hartard, 
et al., 2000) and McArdle’s disease (Vorgerd, Zange, Kley, Grehl, Husing, Jager, et al., 
2000). Incidentally many muscle wasting diseases are associated with irregularities in Cr 
metabolism (Haff, Kirksey, & Stone). However Cr supplementation is not an effective 
technique in the “treatment” of all muscle wasting diseases as Cr supplementation was 
unable to improve the functional capacity in people inflicted with chronic progressive 
external ophthalmoplegia or mitochondrial myopathy (Hespel, Eijnde, Van Leemputte, 
Urso, Greenhaff, Labarque, et al., 2001; Klopstock, Querner, Schmidt, Gekeler, Walker, 
Hartard, et al., 2000).  
Research has also found Cr supplementation to enhance muscle size and strength 
following disuse muscle atrophy leading Hespel et al. (2001) to suggest Cr can be 
effective at preventing and or reversing neuromuscular degeneration in humans. In a 
study examining the role of PCr and Cr in muscle metabolism Cr depleted rats 
experienced atrophy in fast twitch-glycolytic muscle fibers (Meyer, Brown, Krilowicz, & 
Kushmerick, 1986) followed by a study which found Cr supplementation to significantly 
enhance protein content in rat muscle as a result of increases in myofibrillar proteins 
(Flisinska-Bojanowska, 1996). These results suggest the consumption of Cr to promote 
an increased rate of myofibular synthesis contributing to increases in lean body mass 
(Haff, Kirksey, & Stone, 1999). Other studies have found Cr supplementation in 
conjunction with resistance training to result in increases in lean body mass (Haff, 
Kirksey, & Stone). An additional study examining in vitro supplementation of Cr in rats 
found an increased synthesis rate of myosin heavy chains and actin when they are formed 
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in vitro and in vivo (Haff, Kirksey, & Stone). Gyrate atrophy patients were also found to 
have increased fast twitch-glycolytic muscle fiber diameter after consuming 1.5 g of Cr 
per day for 1 year (Haff, Kirksey, & Stone; Sipila, Rapola, Simell, & Vannas, 1981).  
Numerous studies have found Cr supplementation to positively influence the 
health of people with heart problems (Andrews, Greenhaff, Curtis, Perry, & Cowley, 
1998; Fagbemi, Kane, & Parratt, 1982; Gordon, Hultman, Kaijser, Kristjansson, Roll, 
Nyquist, et al., 1995; Haff, Kirksey, & Stone, 1999; Hearse, Tanaka, Crome, & Manning, 
1986; Robinson, Braimbridge, & Hearse, 1984; Pauletto & Stumia, 1996) and others 
undergoing cardiac surgery (Pauletto & Stumia). Gordon et al. (1995) have found 1 week 
of Cr supplementation to benefit chronic heart failure patients by improving muscular 
strength and endurance. Another study involving chronic heart failure patients found PCr 
to significantly improve left ventricular systolic and diastolic function (Pauletto & 
Stumia) while other studies have found PCr to exert antiarrhythmic properties (Fagbemi, 
Kane, & Parratt; Haff, Kirksy, & Stone; Hearse, Tanaka, Crome, & Manning, 1986). PCr 
has been administered to people during cardiac surgery and because of PCr’s ability to 
provide myocardial protection from acute ischemic injury and preoperative ischemic 
damage as a treatment for acute myocardial infarction (Pauletto & Stumia). Some 
researchers have even suggested that PCr be used in the treatment of chronic heart failure 
patients (Andrews, Greenhaff, Curtis, Perry, & Cowley, 1998; Gordon et al., 1995; Haff, 
Kirksey, & Stone). Cr also improves heart health indirectly as 56 days of Cr 
supplementation was shown to improve blood lipid profiles by decreasing total 
cholesterol and triglycerides in middle-aged males and females diagnosed as 
hypertriglyceridemic (Earnest, Almada, & Mitchell, 1996). Additionally Kreider et al. 
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(1998) found high density lipoproteins (HDL-C) to increase by 13% while very low 
density lipoproteins (VLDL-C) to decrease by 13% in response to 28 days of Cr 
supplementation. 
Cr supplementation may also improve brain function as Norwood, Ingwall, 
Norwood and Fossel (1983) found the CK/PCr system to be a rapidly available source of 
ATP synthesis in the brain, suggesting CK to be a significant enzyme for energy 
metabolism in the brain (Wallimann, Wyss, Brdiczka, Nicolay, & Eppenberger, 1992). 
Moreover Cr supplementation at a dose of 5 g per day for 6 weeks has been shown to 
enhance brain function in vegetarians by significantly improving intelligence test scores 
requiring speed of processing such as the Raven’s Advanced Progressive Matrices and 
working memory performance using a backward digit span test (Rae, Digney, McEwan, 
& Bates, 2003).   
Cr has also been shown to control the rate of actin and myosin biosynthesis, a 
determinant of muscle hypertrophy (Walker, 1979). In 2003 Rawson and Volek 
conducted a meta-analysis which cited a large variability in 1RM (repetition maximum) 
bench press performance with improvements ranging from 3% to 45% among users of 
Cr. Improvements in muscular endurance ranged from 16% to 43% and a negative 
correlation was found between training status and strength increases aided by Cr 
supplementation. A 45% increase in 1RM bench press performance was found in 19 
untrained males (Vandenberghe, Goris, Van Hecke, Van Leemputte, Vangerven, & 
Hespel, 1997) while a 30% increase was found in 14 males with approximately 6 years of 
resistance training experience and a 6% increase was reported in 8 males with 
approximately 11 years of resistance training experience (Rawson & Volek; Volek, 
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Kramer, Bush, Boetes, Incledon, Clark, & Lynch, 1997). The negative correlation found 
between Cr supplementation and strength increases is most likely a function of people 
with more training experience being closer to their genetic potential, thus making it more 
difficult to improve performance (Rawson & Volek). Another mechanism that may 
explain the greater increase in weightlifting performance in untrained participants is that 
most increases in strength during the first few weeks of weight training are due to 
neuromuscular adaptations to exercise (Baechle & Earle, 2000). The possibility exists 
that untrained individuals learned how to use the muscle they possessed more efficiently 
rather than improving performance primarily through Cr consumption.  
Another study compared 1RM strength gains in participants consuming Cr for a 
duration of 4 weeks. The Cr plus training group improved bench press performance by 
18% and leg press performance by 42%. While the Cr without training group improved 
bench press performance by 8% and leg press performance by 16%, suggesting 40% of 
the improvements in weightlifting performance were due to consuming a Cr supplement 
independent of training (Arciero, Hannibal, Nindl, Gentile, Hamed, & Vukovich, 2001; 
Rawson & Volek, 2003). Rawson and Volek (2003) suggest the 60% of unexplained 
variance is most likely attributed to participants being able to train at higher workloads. 
Although the mechanisms for performance enhancement are unknown, it has been 
established that raising baseline Cr levels improves weightlifting performance (Rawson 
& Volek).  
Proposed Mechanisms of Improved Performance 
Several hypotheses have been formulated to explain how Cr improves resistance 
training performance. Possible mechanisms include an increase in lean body mass (Volek 
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et al., 1999), enhanced anticatabolic protection (Parise, Mihic, MacLennan, Yarasheski, 
& Tarnopolsky, 2001), an increase in myosin heavy chain mRNA and protein expression 
(Willoughby & Rosene, 2001), an alteration in the expression of myogenic transcription 
factors (Hespel et al., 2001), increased protein synthesis (Rawson & Volek, 2003) an 
increase in satellite cell mitotic activity (Dangott, Schultz, & Mozdziak, 2000), and or 
increased intensity in individual workouts due to a greater supply of ATP (Casey, 
Constantin-Teodosiu, Howell, Hultman, & Greenhaff, 1996; Rawson & Volek). 
Parise, Mihic, MacLennan, Yarasheski and Tarnopolsky (2001) conducted a study 
examining the effects of Cr supplementation leucine kinetics and mixed muscle-protein 
synthesis in trained individuals. Male and female participants were randomly placed into 
a control group who were supplemented with Cr at an initial dose of 20 grams of Cr per 
day for five days followed by maintenance dose of 5 grams for 3-4 days or placebo group 
who consumed an equivalent amount of a glucose polymer. Cr supplementation was 
found increase muscle PCr and Cr levels in males and females but only reduced leucine 
oxidation (19.6%) and plasma leucine rate of appearance (7.5%) in males; suggesting 
short term Cr supplementation may provide anticatabolic protection for lean muscle 
tissue in males and that tissues responding to the Cr supplementation or the signaling 
response(s) to Cr supplementation may be gender specific. No significant differences 
were found in whole body or mixed muscle protein synthesis (Praise, Mihic, MacLennan, 
Yarasheski, & Tarnopolsky, 2001). 
 In 2001 Willoughby and Rosene conducted a 12 week study composed of 3 
groups (control, placebo and Cr) to examine the effects of Cr supplementation and heavy 
resistance training on muscle strength, myosin heavy chain (MHC) isoform mRNA and 
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MHC protein expression. MHC mRNA expression was found to be significantly greater 
in Type I, IIa and IIx muscle fibers in the Cr supplementation group than the placebo and 
control groups. Moreover MHC protein expression was significantly greater in Type I 
and IIx muscle fibers than the placebo and control groups; no significant difference was 
found between the Cr and placebo groups in IIa fibers but each was significantly greater 
than the control group (Willoughby and Rosene). Past research has found heavy 
resistance training to enhance myofibrillar protein synthesis (Welle, Bhatt, & Thornton, 
1999) and Cr supplementation appears to increase MHC and myofibrillar activity 
enhancing the positive effects from heavy resistance training (Willoughby and Rosene). 
The expression of myogenic transcription factors have been associated in the 
regulation of muscle fiber adaptations that occur during muscle hypertrophy. Which lead 
Hespel et al. (2001) to examine the effects of Cr supplementation on functional and 
structural adaptations of skeletal muscle and the expression of myogenic transcription 
factors during 2 weeks of leg immobilization, resulting in disuse atrophy, followed by an 
exercise rehabilitation program in a double-blind trial involving 22 participants. Leg 
immobilization resulted in a decrease in quadriceps muscle cross sectional area (CSA) by 
approximately 10% and maximal knee extension power by approximately 25% in both 
groups. During the 10 week recovery period the Cr supplementation group recovered at a 
significantly faster rate than the placebo group in terms of CSA and maximal knee 
extension power. The immobilization procedure did not result in myogenic factor protein 
expression in either group; however, in the placebo group myogenin protein expression 
was significantly increased while myogenic regulatory factor (MRF) MRF4 protein 
expression was significantly increased in the Cr group. The increase in MRF4 was also 
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positively correlated with the change in mean muscle fiber diameter. These results 
suggest Cr supplementation promotes muscle hypertrophy during rehabilitative strength 
training and the effect may be caused by a Cr induced increase in MRF4 and myogenin 
expression (Hespel et al., 2001).         
Satellite cell mitotic activity is vital in postnatal muscle growth and Cr 
supplementation is the first oral nutritional supplement to result in enhanced satellite cell 
mitotic activity (Dangott, Schultz, & Mozdziak, 1999). As muscles grow myofiber 
hypertrophy occurs and increases in muscle fiber diameter result in increases in myofiber 
nuclei. Myonuclei do not divide and satellite cells provide the new DNA for enlarging 
myofibers by proliferating and when appropriate donate their nuclei to the enlarging 
myofibers (Moss & Leblond, 1971; see also Dangott, Schultz, & Mozdziak). The 
importance of satellite cells has been demonstrated in a prior study suggesting a decrease 
in satellite cells contribution of nuclei to enlarging muscle fibers resulted in reduced 
muscle growth (Mozdziak, Schultz, & Cassens, 1997). Other research has suggested 
increased satellite cell mitotic activity is necessary to maintain a constant volume of 
cytoplasm surrounding each myonucleus during an increase in muscle size (McCall et al., 
1998; Rosenblatt & Parry, 1993).   
 Dangott, Schultz, and Mozdziak (1999) conducted a study examining the effects 
of Cr supplementation on compensatory hypertrophy and satellite cell mitotic activity in 
rats. Results from this study suggest Cr supplementation in conjunction with increased 
functional load results in significant increases satellite cell mitotic activity in overloaded 
muscles. However, there was no significant increase in satellite cell mitotic activity in the 
non-overloaded muscles. No significant differences were found in myofiber diameter in 
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overloaded and non-overloaded plantaris muscles between the Cr supplemented and 
control groups. This study suggests that Cr supplementation increases satellite cell 
mitotic activity during compensatory hypertrophy in which Cr supplementation in 
conjunction with increased functional capacity increases satellite cell mitotic activity 
(Dangott, Schultz, & Mozdziak). Brannon, Adams, Coniff and Baldwin (1997) have 
conducted a study suggesting that increased functional capacity of a muscle is necessary 
for Cr supplementation to elicit a hypertrophic response in rats.  
It must be noted that Cr supplemented rats had a higher increase in body mass and 
had higher increases in muscle mass, myofiber diameter, and index of satellite cell 
mitotic activity than the control group and the small sample size of 12 rats (6 in each 
group) may account for the reason more significant differences were not found between 
the groups. More significant differences may have been found but muscle fiber type 
changes were introduced to the plantaris muscle of the rats in which myofibers may have 
lost their fast phenotype and developed a slower phenotype during the study (Ianuzzo & 
Chen, 1979; Noble, Tang, & Taylor, 1984; Roy, Talmadge, Fox, Lee, Ishihara, & 
Edgerton, 1997) and other studies have found fast twitch muscle fibers to be more 
responsive to Cr supplementation than slow twitch muscle fibers (Brannon, Adams, 
Coniff, & Baldwin, 1997; Sipila, Rapoloa, Simell, & Vannas, 1981; Syrotuik & Bell, 
2004).  
As of 1999 it was unknown how Cr supplementation was related to increased 
satellite cell mitotic activity, but a link does exist. Cr supplementation may increase Cr 
levels within myofibers (Brannon, Adams, Coniff, & Baldwin, 1997; Casey, Constantin-
Teodosiu, Howell, Hulman, & Greenhaff, 1996; Dangott, Schultz, & Mozdziak, 1999) 
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which increases osmotic pressure on the myofibers (Dangott, Schultz, & Mozdziak) and 
the increased osmotic pressure may lead to increases in muscle size (Brannon, Adams, 
Coniff, & Baldwin). Increased osmotic pressure may indirectly initiate satellite cells to 
proliferate and fuse with myofibers undergoing hypertrophy (Dangott, Schultz, & 
Mozdziak). Dangott, Schultz and Mozdziak (1997) also suggest Cr supplementation 
enhances muscle hypertrophy via a myofiber mechanism because satellite cell mitotic 
activity is controlled by myofibers (Mozdziak, Truong, Macius, & Schulz, 1998).  
 Many studies suggest an increase in body mass from Cr supplementation, long 
term studies ranging from 8 to 140 days suggest Cr can increase total body mass and fat-
free mass (Haff, Kirksey, & Stone, 1999). Increases in body mass due to short-term Cr 
supplementation are most likely explained by water retention, but Balsom, Soderlund, 
Sjodin and Ekblom (1995) suggest that increased body mass resulting from long-term Cr 
supplementation and a resistance training regime may result from increases in fast twitch-
glycolytic muscle fiber diameter, as long-term Cr supplementation stimulates an 
increased myofibular protein synthesis rate. In support of Balsom et al’s. (1995) theory 
numerous studies have suggested that Cr plays a critical role in protein synthesis, in 
which Cr may be the chemical signal linking muscular activity and increased contractile 
protein synthesis during hypertrophy (Haff, Kirksey, & Stone). 
 The majority of research has suggested Cr supplementation to improve 
performance in high intensity, short duration bouts of exercise including sprint cycling 
(Balsom, Ekblom, Soderlund, Sjodinm, & Hultman, 1993; Birch, Noble, & Greenhaff, 
1994; Casey, Constantin-Teodosiu, Howell, Hultman, & Greenhaff, 1996; Prevost, 
Nelson, & Morris, 1997; Syrotuik & Bell, 2004) and resistance training (Greenhaff, 
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Bodin, Soderlund, & Hultman, 1994; Greenhaff, Casey, Short, Harris, Soderlund, 
Hultman, 1993; Rawson & Volek, 2003; Volek et al., 1997) but other studies with similar 
protocols have failed to yield significant performance improvements (Barnett, C., Hinds, 
M., & Greenhaff, 1996; Cooke & Barnes, 1997; Febbraio, Flanagan, Snow, Zhio, & 
Carey, 1995; Kilduff et al., 2002; Stevenson & Dudley, 2001; Syrotuik & Bell). 
Methodological, procedural and or experimental design differences may account for the 
equivocal results but Greenhaff, Bodin, Soderlund and Hultman (1994) have suggested 
the effectiveness of Cr supplementation is dependent upon the extent of elevation 
experienced in intracellular muscle Cr that occurs in each individual. Studies support this 
claim by finding people with lower endogenous Cr levels (vegetarians) to experience 
greater improvements in performance than people with higher endogenous Cr levels prior 
to Cr supplementation (Burke, Chilibeck, Parise, Candow, Mahoney, & Tarnopolsky, 
2003; Syrotuik & Bell). 
There are three proposed interindividual responses to Cr supplementation: 
responders (R), individuals who experience a > 20 mmol·kg-1 dw increase in total 
intramuscular Cr and PCr (Greenhaff, Bodin, Soderlund, & Hultman, 1994; Syrotuik & 
Bell); quasi responders (QR), individuals who experience between a 10-20  mmol·kg-1 
dw increase (Syrotuik & Bell) and nonresponders (NR), individuals who experience < 10 
mmol·kg-1 dw increase (Greenhaff, Bodin, Soderlund, & Hultman; Syrotuik & Bell). 
Greenhaff, Bodin, Soderlund and Hultman (1994) suggest it may be necessary to 
increase total muscle Cr by close to 20 mmol·kg-1 dry weight (dw) from Cr 
supplementation to obtain significant performance improvements. Kilduff et al. (2002) 
support Greenhaff et al’s. (1994) claim by noting significant performance improvements 
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were not obtained in peak force or total work output during repeated isometric 
contractions on bench press in their study as a result of having 4 nonresponders to Cr 
supplementation in the subject pool. The nonresponders experienced increased Cr levels 
of ≤ 21 mmol·kg-1 dw which may have obscured the overall group changes of the 32 
participants in their study (Syrotuik & Bell, 2004).  
People respond differently to stimuli such as resistance training programs and 
ergogenic aids (Bouchard & Malina, 1986; Syrotuik & Bell, 2004; Willams, 1998) 
furthermore genetic research supports the idea of having responders and nonresponders to 
treatments (Syrotuik & Bell). Greenhaff, Bodin, Soderlund and Hultman (1994) suggest 
approximately 20%-30% of individuals fall into the category of NR following 5 days of 
Cr supplementation at a dose of 20 grams per which may account for the lack of 
significant performance improvements in some studies particularly with small sample 
sizes (Syrotuik & Bell).  
Syrotuik and Bell (2004) conducted a study to determine the physiological profile 
of R and NR to Cr supplementation. Participants consisted of 11 males who 
supplemented with Cr for 5 days at a dosage of 0.3 g*kg-1*d-1. Of the 11 participants 3 
were R, 5 were QR, and 3 were NR. There was a descending trend regarding muscle fiber 
composition between the three groups. R had the highest percentage of type II fibers 
(63.1%), followed by QR (45.5%) and NR (39.5%). R and QR had a greater muscle 
cross-sectional area than NR pre and post Cr supplementation. R and QR had mean cross-
sectional areas for type I (1,509 and 1,270 υm2), type IIa (1,807 and 2,238 υm2) and type 
IIb (1,695 and 1,740 υm2) compared to NR with type I (900 υm2), type IIa (1,377 υm2), 
and type IIb (1,213 υm2). R had greater mean muscle fiber increases than NR, type I (320 
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verse 60 υm2), type IIa (971 verse 46 υm2), and type IIb (840 verse 78 υm2). A 
descending trend was also found in body mass and fat free mass between the groups. R 
had the greatest increase in total body mass (2.4 kg) and fat free mass (2.0 kg), followed 
by QR (2.1 kg and 1.9 kg) and NR (1.9 kg and 1.7 kg). R improved maximal leg press 
performance by 25.8 kg followed by QR (2.5 kg) and NR (2.0 kg). The best determining 
factors determining the effectiveness of Cr supplementation were muscle fiber 
distribution and muscle CSA (Syrotuik & Bell). 
Creatine Supplementation and Nutritional Choices 
Nutritional choices also play a role in the effectiveness of Cr supplementation as 
caffeine may negate some of the positive performance benefits received from Cr 
supplementation (Vandenberghe, Gillis, Van Leemputte, Van Hecke, Vanstaple, & 
Hespel, 1996). A study conducted by Vandenberghe et al. (1996) was composed of three 
groups: a placebo group, a Cr group and a Cr plus caffeine group. The Cr and Cr plus 
caffeine groups significantly increased intramuscular PCr concentrations, however only 
the Cr group experienced significant improvements in dynamic torque production. In 
1998 another study was published examining the effects of caffeine on Cr 
supplementation and was composed of the same three groups: a placebo group, a Cr 
group and a Cr plus caffeine group (Vanakoski, Kosunen, & Meririnne, 1998). As in the 
Vandenberghe et al. (1996) study researchers found that caffeine had no effect on Cr 
absorption, however researchers did not find any significant performance improvements 
in any of the groups in anaerobic or aerobic performance. Anaerobic performance was 
measured by maximal pedaling speed (rpm), maintenance of maximal speed (rpm) (or 
total work output (kJ)) during 1 minute cycling bouts. Aerobic measurements were made 
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by 45 minutes of cycling at a constant speed. No statistical differences were found 
between the groups for heart rate or blood lactate during aerobic or anaerobic exercise. 
Sample sizes in each study were small, 9 and 7 participants respectively.  
Cr absorption rates are not affected by the consumption of caffeine so 
theoretically performance improvements gained from Cr should not be affected by 
caffeine, however no evidence exists to support this claim. In both studies Cr 
supplementation in the caffeine plus Cr group failed to significantly improve 
performance. Clearly more research needs to be conducted on this topic before a stance 
can be taken of the effectiveness of Cr supplementation when consumed in conjunction 
with caffeine. 
Protein and carbohydrate consumption in conjunction with Cr supplementation 
have been found to significantly affect Cr absorption rates, due to insulin release 
(Steenge, Simpson, & Greenhaff, 2000). Numerous studies and books have reported 
insulin release due to carbohydrate consumption (Green, Hultman, Macdonald, Sewell, & 
Greenhaff, 1996; Steenge, Lambourne, Casey, Macdonald, & Greenhaff, 1998; Ivy & 
Portman, 2004; Powers & Howely, 2004; Steenge, Simpson, & Greenhaff) and insulin 
appears to aid Cr retention in response to Cr supplementation. Studies have shown 
carbohydrate or a combination of carbohydrate and protein consumption in conjunction 
with Cr supplementation to significantly enhance muscle Cr retention (Steenge, Simpson, 
& Greenhaff) as insulin release at concentrations of approximately 100 mU/l or greater 
can enhance Cr retention in human skeletal muscle (Steenge, Lambourne, Casey, 
Macdonald, & Greenhaff, 1998). Cr retention rates have been shown to be enhanced by 
approximately 25% (Steenge, Simpson, & Greenhaff) to 60% when a creatine 
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supplement is consumed with an insulin releasing stimulus (Green, Hultman, Macdonald, 
Sewell, & Greenhaff; Green, Simpson, Littlewood, Macdonald, & Greenhaff, 1996; 
Steenge, Simpson, & Greenhaff). The wide variability in enhanced retention rates may be 
due to functional differences between the studies in which urinary Cr analyses were 
conducted at 40 and 24 hours respectively following consumption of a Cr supplement 
(Steenge, Simpson, & Greenhaff). 
Cr retention following supplementation varies among participants from no 
retention to a recorded 40 mmol/kg dm increase (Green, Hultman, Macdonald, Sewell, & 
Greenhaff, 1996; Greenhaff, 1996; Steenge, Simpson, & Greenhaff, 2000; See also 
Greenhaff, Casey, Short, Harris, Souderlund, & Hultman, 1994; Harris, Soderlund, & 
Hultman, 1992). Variables such as muscle fiber type (Syrotuik & Bell, 2004), age 
(Rawson, Clarkson, Price, & Miles, 2002; Rawson & Clarkson, 1999), endogenous Cr 
levels (Shrier, 2004) and insulin release affect absorption rates (Steenge, Simpson and 
Greenhaff, 2000; Walker, 1979). Moreover individuals with similar pre-supplementation 
Cr concentrations have been found to vary in Cr retention as much as six-fold (Steenge, 
Simpson, & Greenhaff), however the consumption of carbohydrates in conjunction with 
Cr supplementation has been found to reduce interindividual variability in the amount of 
muscle Cr retention during supplementation. In one study all 12 participants experienced 
an increase in muscle total creatine (TCr) of ≥ 20 mmol/kg dm which is equivalent to 
responders of Cr supplementation (Syrotuik & Bell, 2004). The Steenge, Simpson and 
Greenhaff study suggests a stimulatory effect of carbohydrates on muscle Cr retention 
due to insulin release stimulating sodium-potassium pump activity (See also Haugland, & 
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Chang, 1975). This research is consistent with animal based research that suggested 
insulin to increase Cr absorption (Walker, 1979).  
Steenge, Simpson and Greenhaff (2000) also found that consuming 50 g of 
protein in conjunction with 47 g of carbohydrates is as effective as consuming 96 g of 
carbohydrates at increasing Cr retention following Cr supplementation and is 
significantly more effective at increasing Cr retention while consuming a Cr supplement 
in conjunction with 5 g or 50 g of carbohydrates. The mechanism explaining this 
phenomena is that even though glucose is the primary regulator of pancreatic insulin 
release several proteins have been found to stimulate insulin secretion (Spiller, Jensen, 
Pattison, Chuck, Whittam, & Scala, 1987; Steenge, Simpson, & Greenhaff) and the 
consumption of proteins in conjunction with carbohydrates can result in greater increases 
in serum insulin concentrations then would be expected from summing individual serum 
insulin responses from the consumption of protein or carbohydrates independent of each 
other (Steenge, Simpson, & Greenhaff). The results of the Steenge Simpson and 
Greenhaff study suggest the consumption of protein in conjunction with carbohydrates 
has an insulin-potentiating and blood glucose-moderating effect (Steenge, Simpson, & 
Greenhaff), as insulin promotes the entrance of Pi into muscle tissue as a result of insulin 
release (Green, Hultman, Macdonald, Sewell, & Greenhaff, 1996).  
The effects of Cr retention from insulin release are reduced within 24 hours of the 
initial consumption of a Cr supplement thus the longer a Cr supplement is consumed the 
less effect insulin has on Cr retention (Steenge, Simpson, & Greenhaff, 2000). As a 
whole Cr retention may diminish over time as the body nears maximal Cr storage 
capacity (Rawson & Volek, 2003). However research has found the consumption of 5 g 
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of Cr in conjunction with 94 g of carbohydrates four times a day over a period of 5 days 
to increase total muscle Cr accumulation in participants by 62.7% over the amount of Cr 
retained in participants who consumed a Cr supplement without carbohydrates (Green, 
Hultman, Macdonald, Sewell, & Greenhaff, 1996).  
Insulin, insulin-like growth factor I, triiodothyronine and amylin have also been 
shown to stimulate sodium-potassium ATPase pump activity enhancing Cr transport in 
muscle cells (Persky & Brazeau, 2001; Steenge, Simpson, & Greenhaff, 2000). Cr 
primarily enters muscles by binding to a specific transporter protein and is transported 
into muscles against a high-concentration gradient (Guerrero-Onriveros & Wallimann, 
1998; Steenge, Simpson, & Greenhaff). However the amount of Cr transporter protein 
may be reduced when the body is exposed to prolonged periods of high plasma Cr 
concentrations, as such transporter proteins may serve as a regulator of muscle Cr content 
(Steenge, Simpson, & Greenhaff). Studies have also suggested that a slowing of muscle 
Cr accumulation and or transport occurs in comparable amounts with an increase in 
muscle Cr stores (Harris, Soderlund, & Hultman, 1992; Loike, Zalutsky, Kaback, 
Miranda, & Silverstein, 1988). Additionally sodium-potassium pump inhibition has been 
found to occur during prolonged periods of high plasma Cr concentrations resulting in 
inhibition of cellular Cr transport into muscle tissue, an expected response because Cr 
transport into muscle is sodium dependent (Steenge, Simpson, & Greenhaff).  
Population Differences Effect Creatine Supplementation 
 Cr absorption in response to supplementation is also affected by population 
characteristics. Vegetarians have lower endogenous Cr levels and have been found to 
benefit more from Cr supplementation than individuals who regularly consume meat 
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(Shrier, 2004). The elderly population (> 68 years) have also been found to possess lower 
endogenous Cr levels than the younger population (Rawson, Clarkson, Price, & Miles, 
2002; Rawson & Clarkson, 2000). The elderly may have lower endogenous Cr levels 
because of lower levels of dietary Cr consumption.  
Differences in Cr absorption rates have also been observed between young and 
old subjects (> 60 years) in which younger populations are better able to absorb Cr than 
older populations (Rawson & Clarkson, 1999; Rawson, Clarkson, Price, & Miles 2002). 
Older populations may also become less efficient at storing Cr because of decreased Cr 
absorption in the gut, less proficient Cr transport in the blood and or less effective muscle 
Cr uptake (Rawson, Clarkson, Price, & Miles). Therefore older individuals may require 
longer supplementation periods or may need to consume higher doses of Cr to reach 
saturation levels in muscles (Rawson & Clarkson). Cr supplementation has been found 
effective at increasing performance in the elderly but results are not as impressive as what 
has been found in younger populations (Rawson & Clarkson). 
Concerns of Consuming a Supplement 
In accordance with the Dietary Supplement Health and Education Act (DSHEA) of 
1994 the Food and Drug Administration (FDA) is no longer responsible for regulating the 
effectiveness or safety of dietary supplements (Congeni & Miller, 2002). A dietary 
supplement is defined as a product taken by mouth that contains a “dietary ingredient” 
intended to supplement the diet. Dietary ingredients can include vitamins, minerals, 
herbs, other botanicals, amino acids, and substrates such as enzymes, organ tissues, 
glandulars and metabolites. Under the DSHEA bill the law does not require 
manufacturers and/or distributors of supplements to investigate or forward reports they 
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receive of injuries or illnesses that may be related to the use of their products to the FDA. 
Moreover the FDA cannot remove a supplement from the market until they provide 
evidence suggesting the supplement is unsafe (U.S. Food and Drug Administration, 
2001). 
Under current regulations the FDA does not ensure supplements contain the 
ingredients manufacturers place on the label and as of 2001 the FDA had not established 
a minimum standard of practice for supplement manufacturers (U.S. Food and Drug 
Administration, 2001). Manufacturers must only provide evidence to the FDA suggesting 
a supplement is reasonably safe before introducing the product to the market. 
Additionally no evidence must be presented to the FDA suggesting the safety of a 
supplement if the dietary ingredient(s) is found in foods or the ingredient(s) was 
marketed before October 15, 1994 (U.S. Food and Drug Administration, 2001); Cr falls 
under each of these categories. It is also important to note the FDA does not regulate 
serving size or amount of a nutrient in a supplement (U.S. Food and Drug 
Administration, 2001). As a result most companies suggest a loading phase of consuming 
20-25 grams of Cr a day for a period of 4 to 5 days followed by a maintenance dosage of 
5 grams a day (Juhn, 1999). A loading phase of 10 grams a day for 4 days has been 
shown to sufficiently load the body with Cr and a maintenance phase of 2 g or more 
specifically 0.03 g/kg of body weight per day is enough to maintain maximal muscle Cr 
concentration (Juhn, O’Kane, & Vinci, 1999). Research has also found the loading phase 
of Cr supplementation to be unnecessary as supplementation with 0.3 g*kg-1*d-1 for a 5 
day period has been found to elevate muscle total Cr and PCr by 10-25% (Syrotuik & 
Bell, 2004). 
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Possible Negative Effects of Creatine Supplementation 
 As of 1999 the FDA officially logged 32 complaints regarding Cr 
supplementation including seizure, cardiac arrhythmia, cardiomyopathy, deep venous 
thrombosis, rhabdomyolysis and death. However, no conclusions have been made linking 
the complaints in these reports to Cr supplementation (Juhn, O’Kane, & Vinci, 1999), 
moreover most research conducted on Cr supplementation has no reported adverse side 
effects except weight gain viewed as a negative (Juan, 1999). In 1999 Haff, Kirksey and 
Stone reported that 80 research articles in peer-reviewed journals and approximately 70 
papers presented at professional conferences only one demonstrated the occurrence of 
side effects from Cr supplementation. 
Despite accumulating evidence suggesting the safety of short term Cr 
supplementation the media has reported anecdotal claims suggesting Cr supplementation 
can increase the occurrence of muscle cramps, muscle strains, increase renal stress and 
cause liver damage. An apparent fallacy of Cr supplementation is that individuals who 
consume Cr and train in hot and humid climates experience an increased likelihood of 
muscle cramps. A study by Williams and Brach (1998) suggests that Cr supplementation 
results in a fluid balance shift where more water enters muscle cells which could 
theoretically alter electrolyte balance, promote dehydration and possibly increase thermal 
stress. However a study by Kilduff et al. (2004) provides evidence contradictory to this 
hypothesis. Participants consisted of 21 endurance trained males who performed two tests 
to exhaustion at 63 +/- 5% of VO2 max. During the first trial participants were not given 
any supplements. For 7 days before the second trial participants consumed either 20 g a 
day of a Cr supplement or a placebo and exercised in a hot environment (30.3 +/- 0.5 C). 
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As a whole Cr supplementation did not significantly improve performance, but did 
increase intracellular water and reduced thermoregulatory and cardiovascular responses 
by decreasing heart rate, rectal temperature and sweat rate compared to the placebo 
group. Additionally participants identified as responders significantly improved time to 
exhaustion. 
Haff, Kirksey and Stone (1999) found no data from scientific literature suggesting 
that muscle cramping occurs with Cr supplementation. In a study examining the effects of 
Cr supplementation during training and the incidence of muscle cramping, injuries, and 
gastrointestinal distress on 164 athletes of which 80 consumed a Cr supplement. No 
injuries or muscle cramping were reported during the study (Kreider, Rasmussen, 
Ransom, & Almada, 1998). Moreover in a 3.5 year retrospective study on the long term 
health effects of Cr supplementation there were no reported incidence of muscle 
cramping from any participants (Schilling, Fry, Kearney, Smith, O’Bryant, Utter, et al., 
1998). The current literature on Cr supplementation does not support the claim that Cr 
supplementation increases the likelihood of muscle cramps (Haff, Kirksey, & Stone). 
 Another concern is that Cr supplementation may increase renal stress and possibly 
damage the liver as high protein diets have been shown to impair kidney function. The 
ingestion of a high protein meal or a solution of amino acids can increase renal blood 
flow and the glomerular filtration rate (GFR) by up to 20%, placing added stress on the 
kidneys (Culpepper, 1998). Animal models of renal injury suggest that high protein diets 
increase proteinuria which slows the decline in the GFR (Culpepper). As of 1998 it was 
unknown if Cr supplementation as a result of amino acid metabolism could produce 
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similar effects (Culpepper) but the only link of Cr supplementation and renal stress has 
been reported in a male with pre-existing liver failure (Pritchard & Kalra, 1998). 
In 1998, the Lancet published a case study of a 25 year old male with focal segmental 
glomerulosclerosis and frequently relapsing steroid-responsive nephritic syndrome who 
experienced an adverse side effect to Cr supplementation. The patient had been 
consuming a Cr supplement at the suggested dose for 7 weeks and during this period 
doctors diagnosed him with renal dysfunction. Upon advice from his doctors the male 
stopped using the Cr supplement and his kidneys began to function properly. Results 
from this study provide researchers with strong evidence that Cr supplementation was 
responsible for renal dysfunction in this case (Pritchard & Kalra, 1998). However, Haff, 
Kirksey and Stone (1999) identified several clinical studies (Alamada, Mitchell, & 
Earnest, 1996; Earnest, Alamada, & Mitchell, 1996; Poortmans, Auquier, Renaut, 
Durussel, Saugy, & Brisson, 1997; Poortmans & Francaux, 1998) that have not shown Cr 
to negatively affect liver or kidney function. Additionally Poortmans and Francaux 
(1998) found Cr supplementation to have no effect on markers of renal stress. In a 3.5 
year retrospective study on Cr supplementation researchers reported no increases in 
markers of renal stress (Schilling et al., 1998). The current body of literature suggests 
there is no significant increase in renal stress when a Cr supplement is consumed at the 
suggested dosage for up to 3.5 years.    
The last concern from the media surrounding Cr supplementation involves the 
possible long term side effects. Research is not widely available on the long term effects 
of Cr supplementation but Cr has been prescribed as a long term treatment for medical 
conditions in which no side effects have been reported (Sipila, Rapola, Simell, & Vannas, 
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1981; See also Haff, Kirksey, & Stone; 1999). Cr has been administered to participants 
with gyrate atrophy of the choroids and retina daily at a dose of 1.5 g per day for 1 year 
(Sipila, Rapola, Simell, & Vannas). Cr has also been sold as a sport supplement since the 
1980’s and no apparent long term side effects have surfaced, but more research is needed 
before scientists can proclaim the long term use of Cr supplements as safe.  
There was a concern in the scientific community involving the effects of Cr 
supplementation on blood pressure, because Cr is an osmotically active substance it 
raises the amount of water present in muscle cells which increases intracellular water and 
blood volume which may result in increased blood pressure. Peeters, Lantz and Mayhew 
(1999) examined the effects of Cr supplementation on blood pressure over a 6 week 
period in 34 strength trained males (20 Cr supplementation: 11 CrM, 9 CrP and 14 
placebo) and found no significant changes in blood pressure.   
A valid concern surrounding Cr supplementation is that endogenous Cr production is 
suppressed during the course of supplementation. However, in two studies conducted by 
Walker endogenous Cr production resumed following cessation of Cr supplementation 
(Walker, 1960; Walker, 1979; See also Haff, Kirksey, & Stone; 1999). More research 
needs to be conducted involving the effects of Cr supplementation on the biosynthesis of 
endogenous Cr production particularly in the long term with an emphasis placed on new 
steady-state relations that may occur between creatinine and Cr during periods of 
prolonged supplementation (Culpepper, 1998).  
Cr appears to be safe when cycled with periods of consumption and                       
non-consumption. The most common short term side effects of Cr supplementation that 
have been reported are diarrhea, muscle cramps, dehydration and weight gain viewed as a 
 61 
negative effect. In one study involving 52 male collegiate athletes (28 football and 24 
baseball players) side effects were self reported as follows: 16 diarrhea, 13 muscle 
cramps, although only two athletes reported experiencing a sprain or muscle tear, 7 
experienced weight gain viewed as a negative, 7 reported dehydration, 12 reported other 
effects and 14 reported no negative side effects. It must be noted 39 participants exceeded 
the recommended maintenance dose of 2 g to 5 g per day with the most common 
maintenance dose being 6 g to 8 g per day; while 18 participants consumed 9 g or more 
per day and 18 participants consumed 17 g to 20 g per day as a maintenance dose. 
Despite the reported side effects, 40 athletes (77%) reported they plan to continue using 
Cr or plan on using Cr in the future (Juhn, O’Kane, & Vinci, 1999).  
In a similar study on the perceived effects of Cr supplementation on division I 
collegiate athletes similar results were found. Of the 219 athletes surveyed 90 athletes 
(41%) reported using a Cr supplement and 80 athletes (89%) reported perceived positive 
effects while 34 athletes (38%) reported perceived negative side effects and 10 athletes 
(11%) reported no effects. It is important to note every athlete who reported a perceived 
negative effect of Cr supplementation also reported a positive effect. In each group there 
was a trend to use a lower than recommended loading phase dose and a higher than 
recommended maintenance phase dose suggesting there is a need to education athletes on 
the proper use of Cr supplementation (Greenwood, Farris, Kreider, Greenwood, & Byars, 
2000). 
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COLLEGE OF COLLEGE OF HEALTH AND HUMAN SCIENCES 
DEPARTMENT OF JIANN-PING HSU SCHOOL OF PUBLIC HEALTH 
 
INFORMED CONSENT 
I understand that study I am about to participate in part of a research project 
entitled The Relationship between Endogenous Creatine Levels, Maximal Upper 
Body Strength, Body Fat and Short-Term Muscle Recovery in Males, conducted 
by Vinny Dalbo (912-871-1991), a graduate student at Georgia Southern 
University. The purpose of this study is to examine if endogenous (naturally 
occurring) creatine levels present in the human body can influence indices of 
athletic performance and general health.  
Participation in this research study requires two meetings with the 
experimenter over a four day period. Participation will include completion of a 
three day food diary and a demographic questionnaire during the first meeting. 
The second meeting requires a blood test of less than 10 mL of blood, an eight 
hour fast, measurement of height, weight, and body fat percentage (using the 
Jackson-Pollack 3-site skin fold assessment). Participants will also be asked to 
complete a one repetition maximum bench press test, and five repeated maximal 
effort bench press lifts with 80% of the participant’s one repetition maximum, 
with two minute rest intervals between sets.  
It is not believed nor are the three day food diary or demographic 
questionnaire intended to cause any psychological discomfort to any participant. 
Minimal amounts of physical discomfort may be experienced during the blood 
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test, which will be conducted by a licensed phlebotomist and the exercise portion 
of the test. Participants will be asked to exert maximal effort during the one 
repetition maximum test and the muscle recovery portion of the test. Discomfort 
experienced from lifts should be minimal as participants should have at least one 
year weight training experience and should be accustom to weight training. “I 
understand that medical care is available in the event of injury resulting from 
research but that neither financial compensation nor free medical treatment is 
provided.  I also understand that I am not waiving any rights that I may have 
against the University for injury resulting from negligence of the University or 
investigators.” For those who wish to seek assistance following completion of the 
study may contact Vinny Dalbo (912-871-1991), the Counseling Center (912-681-
5541) and or Health Services. 
I understand that any relationship between myself and the information I 
contribute to this study will be kept confidential. I understand that I may stop 
answering any question at any time without prejudice to myself, course grade, 
employment status or any other personal matter. For students in which extra credit 
is offered for completion of the study, I understand that by answering all of the 
questions in the assessment and completing the physical aspect of the test, I may 
be able to receive extra credit to my final numerical grade. I understand that if I 
do terminate the study, I will not receive extra credit, but will be allowed to 
complete the compensatory extra credit assignment.  
As a participant you have the right to ask questions and have those questions 
answered. If you have questions about this study, please contact Vinny Dalbo 
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(912-871-1991) or Dr. Jim McMillan (912-871-1926). For questions concerning 
your rights as a research participant, contact Georgia Southern University Office 
of Research Services and Sponsored Programs (912-486-7758).  
No monetary compensation is offered for participation in this study and 
participation is voluntary. You the participant are in no way required to 
participate in this study and may end your participation at any time by telling the 
person in charge or not returning the questionnaires. You also reserve the right to 
not answer any question(s) you do not want to answer. You may chose to not 
participate, stop participation, and or not answer any question(s) without penalty. 
You must be 18 years of age or older to consent to participate in this research 
study.  If you consent to participate in this research study and to the terms above, 
please sign your name and indicate the date below. You will be given a copy of 
this consent form to keep for your records. 
 
 
Title of Project: The Relationship between Endogenous Creatine Levels, Maximal Upper 
Body Strength, Body Fat, and Short Term Muscle Recovery in Males  
Principal Investigator: Vinny Dalbo, 2218 Hanner Field House, telephone: 912-871-1991, 
vincent_j_dalbo@GeorgiaSouthern.edu 
Faculty Advisor: Dr. Jim McMillan, Hollis Building, 912-871-1926, 
jmcmillan@GeorgiaSouthern.edu 
  
 
______________________________________  _____________________ 
Participant Signature     Date 
 
I, the undersigned, verify that the above informed consent procedure has been followed. 
 
______________________________________  _____________________ 
Investigator Signature     Date 
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Name:          Day 1 (Use the back of the sheet if needed.) 
 
 
 
Food Type (Include 
Drinks) 
Include brand and 
names (eg. Kellogg’s 
Oatbran cereal, KFC 
chicken wings Ocean 
Spray Cranberry 
Juice) 
 
Food Preparation 
(Ingredient list, type of 
preparation: baked or 
fried, etc) 
Serving Size/number of 
servings 
(include ounces, fluid 
ounces, milli – liters, 
cups, teaspoons, etc) 
 
Breakfast 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lunch  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dinner 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Snacks   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maintain a 3-day food record on three consecutive days. Be sure to include extras (i.e. 
– sugar in tea, cream in coffee, butter on popcorn, etc.) when recording your intake. 
Estimate the amount to the nearest common household measure such as teaspoon, cup or 
ounces. Please ensure your records are accurate as possible.  
 
 
 89 
Name:          Day 2 (Use the back of the sheet if needed.) 
 
 
 
Food Type (Include 
Drinks) 
Include brand and 
names (eg. Kellogg’s 
Oatbran cereal, KFC 
chicken wings Ocean 
Spray Cranberry 
Juice) 
 
Food Preparation 
(Ingredient list, type of 
preparation: baked or 
fried, etc) 
Serving Size/number of 
servings 
(include ounces, fluid 
ounces, milli – liters, 
cups, teaspoons, etc) 
 
Breakfast 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lunch  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dinner 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Snacks   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maintain a 3-day food record on three consecutive days. Be sure to include extras (i.e. 
– sugar in tea, cream in coffee, butter on popcorn, etc.) when recording your intake. 
Estimate the amount to the nearest common household measure such as teaspoon, cup or 
ounces. Please ensure your records are accurate as possible.  
 
 
 90 
Name:          Day 3 (Use the back of the sheet if needed.) 
 
 
 
Food Type (Include 
Drinks) 
Include brand and 
names (eg. Kellogg’s 
Oatbran cereal, KFC 
chicken wings Ocean 
Spray Cranberry 
Juice) 
 
Food Preparation 
(Ingredient list, type of 
preparation: baked or 
fried, etc) 
Serving Size/number of 
servings 
(include ounces, fluid 
ounces, milli – liters, 
cups, teaspoons, etc) 
 
Breakfast 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lunch  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dinner 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Snacks   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maintain a 3-day food record on three consecutive days. Be sure to include extras (i.e. 
– sugar in tea, cream in coffee, butter on popcorn, etc.) when recording your intake. 
Estimate the amount to the nearest common household measure such as teaspoon, cup or 
ounces. Please ensure your records are accurate as possible.  
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Demographic Questionnaire 
ID# _________ 
Section I 
1. Age (in years): ______________ 
2. Gender - Male 
3. How many years have you been weight training: _________ 
4. Are you currently on a weight training regimen? Yes No 
 
If yes answer questions 5, 6, 7, 8 
If no answer question 9  
 
5. What type of rep ranges are you training with most frequently (circle the response that 
most applies)? 
High weight low reps           Moderate weight and reps                Low weight high reps 
(1-8 reps)                                 (8-12 reps)                                             (12 or more reps) 
 
6. What is the average break (rest period) you take between sets in minutes? __________ 
7. How many days per week do you currently lift weights? 
1 2 3 4 5 6 7  
8. Have you consistently been lifting weights 3 or more days per week for the last 30 
days? 
Yes No 
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9. How many months have passed since you consistently lifted weights 3 or more days 
per week for 30 days? _________ 
 
Section II 
1. Have you ever consumed a sport supplement? Yes  No 
2. Have you ever consumed a supplement containing creatine?  Yes No 
3. Have you consumed a sport supplement in the past 2 months? Yes No 
4. If yes what supplement(s)? 
_____________________________________________________ 
 
5. Have you consumed a supplement containing creatine in the past 4 months? Yes    No 
If yes what supplement(s)? 
_______________________________________________________ 
 
6. When was the last time you consumed a sport supplement (answer in months)? 
________________________________________________________________________ 
 
7. What was the last sport supplement you consumed? 
________________________________________________________________________ 
 
8. On average how many days per week do you weight train? 
1 2 3 4 5 6 7  
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9. On average how many days per week do you exercise? 
1 2 3 4 5 6 7   
 
10. Are you a hemophiliac? (trouble stopping bleeding) Yes No 
11. Do you have diabetes? Yes No 
12. Do you have any liver problems? Yes No 
13. If yes, what problems do you have: 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________  
14. Do you have any kidney problems? Yes No  
15. If yes, what problems do you have: 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
16. Do you have any blood born illnesses? Yes No 
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DATA SHEET 
ID # ____________ 
 
Height ________________   Weight ________________ 
 
Skin fold measurements 
 First Second Third Average 
Chest     
Abdomen     
Thigh     
 
1RM _______________________   80% 1RM ___________________ 
 
Set # # of Reps 
1  
2  
3  
4  
5  
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Proper Bench Press and Spotting Technique 
Beginning Position: Athlete 
Starting position: Assume supine position on a bench in a five-point body contact 
position. Place body on bench so that eyes are below the edge of the supports. Grasp the 
bar with a closed pronated grip. Grip should be slightly wider than shoulder-width. Signal 
the spotter for assistance in moving the bar off the supports. Place the bar over the chest 
with elbows fully extended. All subsequent repetitions begin from this position.   
 
Downward Movement Phase: Athlete 
Lower the bar to touch the chest at approximately nipple level. Keep the wrists ridged 
and directly above the elbows. Maintain the five-point body contact position. 
 
Upward Movement Phase: Athlete 
Push the bar upward until the elbows are fully extended. Keeps wrists ridged and directly 
above the elbows. Maintain five-point body contact position. Do not arch back or raise 
chest to meet the bar. After the set is completed, signal the spotter for assistance in 
racking the bar. Keep a grip on the bar until it is racked.  
 
Beginning Position: Spotter 
Stand erect and very close to the head of the bench. Place feet should-width apart with 
knees slightly flexed. Grasp the bar with a closed, alternated grip inside the athlete’s 
hands. At athlete’s signal, assist in moving the bar off the supports. Guide the bar to a 
position over the athlete’s chest. Release the bar smoothly. 
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Downward Movement Phase: Spotter 
Keep hands in the alternated grip position close to-but not touching-the bar as it 
descends. Slightly flex the knees, hips, and torso and deep the back flat when following 
the bar.  
 
Upward Movement Phase: Spotter 
Keep the hands in the alternated grip position close to-but not touching-the bar as it 
ascends. Slightly extend the knees, hips, and torso and keep the back flat when following 
the bar. At the athlete’s signal after the set is completed, grasp the bar with an alternated 
grip inside the athlete’s hands. Guide the bar back onto the supports. Keep a grip on the 
bar until it is racked.  
 
Note. From Essential of strength training and conditioning (2nd ed.) (p.359), by T. R. 
Baechle and R. W. Earle, 2000, Champaign: National Strength and Conditioning 
Association. 
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Jackson Pollock 3-Site Skin Fold Equation 
Male 3-Site Equation (SUM3 = chest, abdomen, thigh) 
Db = 1.10938 - (0.0008267 * SUM3) + (0.0000016 * SUM32) - (0.000257 * AGE)  
%BF = [(4.57/ Db) - 4.142] * 100 
 
Body Density 
Black Male Age 19-45 = (4.86)/Db – 4.39 
White Male Age 17-19 = (4.99)/Db – 4.55 
White Male Age 20-80 = (4.95)/Db – 4.50 
 
 
Jackson, A.S., & M.L. Pollack. Practical Assessment of body composition. Physician
 Sport Medicine, 13:76-90, 1985. (As published in: Nieman DC: The Sports
 Medicine Fitness Course. Bull Publishers. Palo Alto, 1986, pp. 101. 
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NSCA One Repetition Maximum Bench Press Protocol 
Equipment 
• Olympic-style weightlifting set with enough total weight to accommodate the 
maximum lift of the strongest athlete and a variety of plate sizes to allow for 5-lb 
gradations in weight. 
• A sturdy bench-press bench with integral bar rack of adjustable height.  
 
Procedure 
1. Instruct the athlete to warm-up with a light resistance that easily allows 5-
10 repetitions. 
2. Provide a 1-minute rest period. 
3. Estimate a warm-up load that will allow the athlete to complete 3-5 
repetitions by adding 
• 10-20 lb or 5-10% 
4. Provide a 2-minute rest period. 
5. Estimate a conservative, near-maximum load that will allow the athlete to 
complete 2-3 repetitions by adding 
• 10-20 lb or 5-10% 
6. Provide a 2 to 4-minute rest period. 
7. Make a load increase 
• 10-20 lb or 5-10% 
8. Instruct the athlete to attempt a one repetition maximum lift. 
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9. If the athlete was successful, provide a 2 to 4-minute rest period and go 
back to step 7. 
If the athlete failed, provide a 2 to 4-minute rest period, decrease the load 
by subtracting 
• 5-10 lb or 2.5-5% 
AND then go back to step 8. 
 
Continue increasing or decreasing the load until the athlete can complete 
one repetition with proper exercise technique. Ideally, the athlete’s one 
repetition maximum will be measured within five testing sets.  
 
Note. From Essential of strength training and conditioning (2nd ed.) (p.409), by T. R. 
Baechle and R. W. Earle, 2000, Champaign: National Strength and Conditioning 
Association. 
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 105 
Extended Creatinine Analysis 
The first step of data analysis required making the 8 standards by combing 
progressively greater amounts of the creatine standard with progressively fewer amounts 
of HPLC-grade water in each of the 8 standard test tubes. Each of the 8 standards was 
placed pipetted into 2 empty wells on a 96 well plate along with the creatinine samples. 
Initial and final absorbance values were recorded at 492 nm on a plate reader. The final 
absorbance was subtracted from the initial absorbance on each of the 8 standards yielding 
the adjusted absorbance. The adjusted absorbance values for each standard was plotted 
and fitted with a trend line yielding the creatinine standard curve (see Figure 2) 
   The next step was to subtract the final absorbance values from the initial 
absorbance values to determine the adjusted absorbance value for each creatinine sample. 
The adjusted absorbance values for each creatinine sample were plugged into the formula 
seen in Figure 3 yielding the creatine values in mg/dl for each participant.  
 
Figure I1. Creatinine standard curve 
________________________________________________________________________ 
 y = 0.0406x – 0.0016 
r2 = 0.9993 
______________________________________________________________________ 
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Figure I2. Creatinine determination formula 
_______________________________________________________________________ 
 Creatinine (mg/dl) = ((sample absorbance – y intercept) / slope) 
______________________________________________________________________ 
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